Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Anixa Biosciences Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 35 | 42 | +7 |
| Shares | 3.18M | 3.44M | +260.5K (+8.2%) |
| Value | $15.2M | $10.2M | −$4.95M (−32.6%) |
New holders (10)
Institutions that held Anixa Biosciences Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CoreCap Advisors, LLC | 34,952 | $104.0K | 0.01% |
| Jump Financial, LLC | 26,000 | $77.0K | 0.00% |
| Long Focus Capital Management, LLC | 21,297 | $63.0K | 0.02% |
| Tyler-Stone Wealth Management | 21,008 | $62.0K | 0.03% |
| Goldman Sachs Group Inc | 16,479 | $49.0K | 0.00% |
| Millennium Management LLC | 15,712 | $47.0K | 0.00% |
| ExodusPoint Capital Management, LP | 10,029 | $30.0K | 0.00% |
| Accel Wealth Management | 1,250 | $4.00K | 0.00% |
| US Bancorp | 400 | $1.00K | 0.00% |
| Ancora Advisors, LLC | 500 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Anixa Biosciences Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Wealth Alliance Advisory Group, LLC | 16,413 | $78.0K |
| Captrust Financial Advisors | 2,500 | $12.0K |
| Global Retirement Partners, LLC | 180 | $1.00K |